Suppr超能文献

酒精性肝硬化和腹膜恶性肿瘤所致腹水的纤溶活性

Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy.

作者信息

Scott-Coombes D M, Whawell S A, Vipond M N, Crnojevic L, Thompson J N

机构信息

Department of Surgery, Hammersmith Hospital, London.

出版信息

Gut. 1993 Aug;34(8):1120-2. doi: 10.1136/gut.34.8.1120.

Abstract

Coagulopathy is a well recognised complication of peritoneovenous shunting for ascites. The relative contributions of primary fibrinolysis and disseminated intravascular coagulation remain controversial. Plasminogen activating activity was significantly lower in malignant ascites (n = 10, median < 0.02 (range < 0.02-1.26) IU/ml) than in alcoholic ascites (n = 10, 1.07 (0.30-1.49) IU/ml) (p < 0.05). Fibrinolytic activity was determined by a balance between tissue plasminogen activator and plasminogen activator inhibitor-1. There was no significant difference between the two groups in the concentration of tissue plasminogen activator (34 (12-64) ng/ml in malignant ascites v 29 (12-43) ng/ml in alcoholic ascites), but the concentration of plasminogen activator inhibitor-1 was significantly higher in malignant ascites (736 (213-1651) ng/ml) than in alcohol ascites (29 (12-43) ng/ml) (p < 0.05). Malignant ascites contained significantly higher concentrations of urokinase (0.7 (< 0.1-1.3) ng/ml v 0.2 (< 0.1-0.6) ng/ml in alcoholic ascites) and plasminogen activator inhibitor-2 (33 (< 6-140) ng/ml v 9 (< 6-28) ng/ml alcoholic ascites). The plasminogen activating activity of alcohol ascites may lead to primary fibrinolysis after peritoneovenous shunting. The considerably lower activity found in malignant ascites may explain why coagulopathy after shunting is less pronounced in this group of patients.

摘要

凝血功能障碍是腹水腹膜静脉分流术一种公认的并发症。原发性纤溶和弥散性血管内凝血的相对作用仍存在争议。恶性腹水(n = 10,中位数<0.02(范围<0.02 - 1.26)IU/ml)中的纤溶酶原激活活性显著低于酒精性腹水(n = 10,1.07(0.30 - 1.49)IU/ml)(p < 0.05)。纤溶活性由组织纤溶酶原激活物和纤溶酶原激活物抑制剂 - 1之间的平衡决定。两组之间组织纤溶酶原激活物浓度无显著差异(恶性腹水中为34(12 - 64)ng/ml,酒精性腹水中为29(12 - 43)ng/ml),但恶性腹水中纤溶酶原激活物抑制剂 - 1的浓度显著高于酒精性腹水(736(213 - 1651)ng/ml比29(12 - 43)ng/ml)(p < 0.05)。恶性腹水中尿激酶(0.7(<0.1 - 1.3)ng/ml比酒精性腹水中的0.2(<0.1 - 0.6)ng/ml)和纤溶酶原激活物抑制剂 - 2(33(<6 - 140)ng/ml比酒精性腹水中的9(<6 - 28)ng/ml)的浓度显著更高。酒精性腹水的纤溶酶原激活活性可能导致腹膜静脉分流术后原发性纤溶。在恶性腹水中发现的活性明显较低,这可能解释了为什么在这组患者中分流术后的凝血功能障碍不那么明显。

相似文献

4
Fibrinolysis and the biliary tree.纤维蛋白溶解与胆管树
Gut. 1997 Jan;40(1):92-4. doi: 10.1136/gut.40.1.92.
6
The fibrinolytic system in human ascites.
Scand J Gastroenterol. 1995 Nov;30(11):1101-7. doi: 10.3109/00365529509101614.

引用本文的文献

本文引用的文献

2
Complications after peritoneovenous shunting for ascites.腹水腹膜静脉分流术后的并发症。
Am J Surg. 1980 Jan;139(1):125-31. doi: 10.1016/0002-9610(80)90241-x.
3
Ascites-induced LeVeen shunt coagulopathy.腹水诱导的LeVeen分流术凝血障碍。
Ann Surg. 1983 Jul;198(1):91-5. doi: 10.1097/00000658-198307000-00018.
7
Coagulopathy post peritoneovenous shunt.腹膜静脉分流术后凝血病
Ann Surg. 1987 Mar;205(3):305-11. doi: 10.1097/00000658-198703000-00015.
8
Plasminogen activators, tissue degradation, and cancer.纤溶酶原激活剂、组织降解与癌症
Adv Cancer Res. 1985;44:139-266. doi: 10.1016/s0065-230x(08)60028-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验